Temporary Final Guidance Issued to Allow for the Compounding of Ibuprofen Oral Suspension Products to Address Shortages

Temporary Final Guidance Issued to Allow for the Compounding of Ibuprofen Oral Suspension Products to Address Shortages

The Food and Drug Administration (FDA) issued immediately in effect final guidance on compounding certain ibuprofen oral suspension products in outsourcing facilities for administration in hospitals and health systems. The agency details that the FDA has received reports related to increased demand for pediatric fever-reducing medication, including ibuprofen oral suspension products, along with health systems and hospitals experiencing challenges in… (Slifer, January 24, 2023) #Food and Drug Administration, #Hospitals, #Prescription Drugs